Pregled bibliografske jedinice broj: 1105518
Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs
Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs // Molecules, 25 (2020), 21; 4937, 20 doi:10.3390/molecules25214937 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1105518 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Small Molecules Targeting Biological Clock; A
Novel Prospective for Anti-Cancer Drugs
Autori
Rahman, Sadia ; Wittine, Karlo ; Sedić, Mirela ; Markova-Car, Elitza P.
Izvornik
Molecules (1420-3049) 25
(2020), 21;
4937, 20
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
circadian rhythm ; biological clock ; cancer ; small molecules ; anticancer drugs
Sažetak
The circadian rhythms are an intrinsic timekeeping system that regulates numerous physiological, biochemical, and behavioral processes at intervals of approximately 24 h. By regulating such processes, the circadian rhythm allows organisms to anticipate and adapt to continuously changing environmental conditions. A growing body of evidence shows that disruptions to the circadian rhythm can lead to various disorders, including cancer. Recently, crucial knowledge has arisen regarding the essential features that underlie the overt circadian rhythm and its influence on physiological outputs. This knowledge suggests that specific small molecules can be utilized to control the circadian rhythm. It has been discovered that these small molecules can regulate circadian-clock-related disorders such as metabolic, cardiovascular, inflammatory, as well as cancer. This review examines the potential use of small molecules for developing new drugs, with emphasis placed on recent progress that has been made regarding the identification of small- molecule clock modulators and their potential use in treating cancer.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-IP-2018-01-3900 - Rasvijetljavanje mehanizama rezistencije na terapiju raka debelog crijeva sa mutacijom BRAF pomoću integriranog -omics pristupa (BRAFCON) (Sedić, Mirela, HRZZ - 2018-01) ( CroRIS)
--uniri-biomed-18-257 - Cirkadijalni geni u planocelularnog karcinoma larinksa (Markova-Car, Elitza Petkova; Markova-Car, Elitza Petkova) ( CroRIS)
Ustanove:
Sveučilište u Rijeci - Odjel za biotehnologiju
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE